AnnJi Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	346.47	629.04	597.86	267.9	391.41
Short-Term Investments	2	76	274	-	-
Trading Asset Securities	-	0.97	5.51	-	-
Cash & Short-Term Investments	348.47	706.01	877.37	267.9	391.41
Cash Growth	-50.64%	-19.53%	227.50%	-31.55%	-
Accounts Receivable	0.14	0.15	-	0.09	-
Other Receivables	0.43	0.67	3.92	12.49	10.51
Receivables	0.56	0.82	3.92	12.58	10.51
Inventory	18.11	27.42	-	4.89	5.31
Prepaid Expenses	2.64	9.56	37.54	20.14	4.95
Total Current Assets	369.78	743.8	918.82	305.51	412.18
Property, Plant & Equipment	68.1	76.4	82.08	6.73	11.18
Long-Term Investments	83.26	79.2	69.78	59.4	39.6
Other Intangible Assets	66.94	100.6	134.57	168.75	202.74
Other Long-Term Assets	2.03	2	2.74	0.84	0.84
Total Assets	590.11	1,002	1,208	541.23	666.54
Accounts Payable	-	0.12	-	-	-
Accrued Expenses	54.53	48.39	48.09	27	11.7
Current Portion of Leases	6.26	5.98	5.8	-	2.79
Current Income Taxes Payable	38.98	40.66	38.08	-	-
Current Unearned Revenue	-	192.73	126.09	1.6	-
Other Current Liabilities	3	2.67	9.55	2.12	1.76
Total Current Liabilities	102.77	290.54	227.6	30.72	16.25
Long-Term Leases	43.1	49.36	55.34	-	-
Other Long-Term Liabilities	124.41	-	-	-	0.16
Total Liabilities	270.29	339.9	282.94	30.72	16.41
Common Stock	940.64	936.92	908.61	658.76	623.76
Additional Paid-In Capital	969.15	961.07	909.67	426.15	384.49
Retained Earnings	-1,658	-1,300	-946.02	-616.8	-380.15
Comprehensive Income & Other	67.9	64.11	52.78	42.4	22.03
Shareholders' Equity	319.82	662.1	925.04	510.51	650.13
Total Liabilities & Equity	590.11	1,002	1,208	541.23	666.54
Total Debt	49.36	55.34	61.13	-	2.79
Net Cash (Debt)	299.11	650.67	816.24	267.9	388.62
Net Cash Growth	-54.03%	-20.28%	204.68%	-31.06%	-
Net Cash Per Share	3.19	7.00	10.55	4.08	8.60
Filing Date Shares Outstanding	94.06	93.69	90.86	65.88	45.2
Total Common Shares Outstanding	94.06	93.69	90.86	65.88	45.2
Working Capital	267	453.26	691.22	274.79	395.93
Book Value Per Share	3.40	7.07	10.18	7.75	14.38
Tangible Book Value	252.88	561.5	790.47	341.76	447.39
Tangible Book Value Per Share	2.69	5.99	8.70	5.19	9.90
Machinery	36.07	33.77	35.05	36.36	36.24
Construction In Progress	-	-	8.03	-	-
Leasehold Improvements	17.01	16.94	7.58	4.28	4.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.